ArticleAnnals of intensive care2023

Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.

Sylvie Chevret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.